Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Conjunctivitis Treatment Market

Conjunctivitis Treatment Market Share

Report ID: GMI8377
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Conjunctivitis Treatment Market Share

The conjunctivitis treatment industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced product based on different technologies is among a key market strategy. Some of the leading industry players including Alembic Pharmaceuticals, Novartis, Ajanta Pharma Limited, and Bausch & Lomb among others have a notable presence in the market.

Conjunctivitis Treatment Market Companies

Some of the eminent market participants operating in the conjunctivitis treatment industry include:

AbbVie Inc.
AFT Pharmaceuticals
Ajanta Pharma Limited
Alembic Pharmaceuticals
Bausch & Lomb Incorporated
Cipla, Inc.
JAWA Pharmaceuticals Pvt. Ltd.
Novartis AG
NicOx SA
Ocular Therapeutics, Inc.
Santen Pharmaceuticals Co. Ltd.
Sun Pharmaceuticals Industries Ltd.
Spectra Vision Care Pvt. Ltd.
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of conjunctivitis treatment reached USD 4.1 billion in 2023 and is set to cross USD 6.3 billion by 2032, owing to the rising prevalence of conjunctivitis from viral outbreaks, bacterial infections, allergies, environmental influences, and increased global travel worldwide.

The anti-allergic segment is expected to reach USD 4.1 billion by 2032, due to the rising prevalence of allergic conditions, such as allergic rhinitis, allergic conjunctivitis, and asthma.

North America market was valued at USD 1.6 billion in 2023, due to growing awareness of conjunctivitis and its treatment options among healthcare professionals and the general population in the region.

AFT Pharmaceuticals, Ajanta Pharma Limited, Alembic Pharmaceuticals, Bausch & Lomb Incorporated, Cipla, Inc., JAWA Pharmaceuticals Pvt. Ltd., Novartis AG, NicOx SA, and Ocular Therapeutics, Inc., are some of the major conjunctivitis treatment companies worldwide.